FYB

Formycon AG

  • Germany
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.04
FY22:
0.03
FY23:
0.07
FY24:
0.10
FY25:
0.13
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.03
FY22:
0.82
FY23:
0.82
FY24:
0.68
FY25:
0.61
Total assets
Change from FY21 to FY25
billions EUR
FY21:
0.07
FY22:
0.85
FY23:
0.89
FY24:
0.77
FY25:
0.74

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.01
FY22:
0.05
FY23:
0.07
FY24:
0.03
FY25:
0.05
(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.00
FY22:
0.45
FY23:
0.32
FY24:
0.28
FY25:
0.29
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.06
FY22:
0.36
FY23:
0.50
FY24:
0.46
FY25:
0.40
Total liabilities & equity
Change from FY21 to FY25
billions EUR
FY21:
0.07
FY22:
0.85
FY23:
0.89
FY24:
0.77
FY25:
0.74

All amounts in billions EUR Data source:Twelve Data